NeoGenomics Laboratories, Inc. Balance Sheet
NEO / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 15 fiscal years. All figures from audited SEC 10-K filings.
NeoGenomics Laboratories, Inc. had $1.4B in total assets and $837M in shareholders' equity as of FY2025. Total debt was $342M against $160M in cash, resulting in $182M net debt.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 0.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $159.6M | $367.0M | $342.5M | $263.2M | $316.8M | $228.7M | $173.0M | $9.8M | $12.8M | $12.5M | $23.4M | $1.9M | $2.6M | $1.1M | $2.6M |
| Accounts Receivable | $159.2M | $150.5M | $131.2M | $119.7M | $112.1M | $106.8M | $94.2M | $76.9M | $60.4M | $55.5M | $48.9M | $20.5M | $18.7M | $14.0M | $7.9M |
| Inventory | $28.6M | $26.7M | $24.2M | $24.3M | $23.4M | $29.5M | $14.4M | $8.7M | $7.5M | $6.3M | $5.1M | $2.6M | $2.3M | $1.9M | $1.2M |
| Current Assets | $376.3M | $596.0M | $596.8M | $605.3M | $681.5M | $448.7M | $290.7M | $103.7M | $85.9M | $78.8M | $82.4M | $58.7M | $27.5M | $18.6M | $13.2M |
| PP&E (Net) | $84.8M | $94.1M | $92.0M | $102.5M | $109.5M | $85.9M | $64.2M | $60.9M | $36.5M | $34.0M | $34.6M | $15.1M | $9.7M | $8.6M | $6.6M |
| Goodwill | $524.3M | $522.8M | $522.8M | $522.8M | $527.1M | $211.1M | $198.6M | $197.9M | $147.0M | $147.0M | $146.4M | $2.9M | - | - | - |
| Total Assets | $1.4B | $1.6B | $1.7B | $1.7B | $1.9B | $988.3M | $709.5M | $505.0M | $344.5M | $337.1M | $351.3M | $81.1M | $39.9M | $30.1M | $19.9M |
| Current Liabilities | $88.3M | $301.2M | $96.3M | $89.9M | $87.2M | $73.2M | $63.9M | $60.9M | $36.5M | $38.1M | $40.1M | $14.6M | $14.3M | $17.8M | $11.4M |
| Total Debt | $341.9M | $541.1M | $538.2M | - | - | - | - | $101.8M | $96.7M | $97.9M | $55.0M | - | - | - | - |
| Shareholders' Equity | $836.6M | $902.3M | $941.5M | $998.0M | $1.1B | $694.3M | $507.4M | $320.4M | $172.0M | $162.3M | $208.5M | $9.2M | $5.9M | $3.1M | $5.9M |